Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions

ConditionsAutoimmune Diseases Cardiovascular Disorders Diabetes Complications Integumentary Disease Musculoskeletal Disorders Neurodegenerative Disorders Neurologic Disorders Pulmonary Disorders Sexual Dysfunction Urologic Disorders Viral Illness

Trial statusRecruiting

Trial phasePhase 1, Phase 2

Trial typeInterventional

Biological sexAll

Age18+

SponsorThomas Advanced Medical LLC

About this trial

This multi-arm, multi-site study investigates the safety, tolerability, and efficacy of stem cell therapy for the treatment of various acute and chronic conditions. Clinically observed initial findings and an extensive body of research indicate regenerative treatments are both safe and effective for the treatment of multiple conditions.

Eligibility criteria

Qualifiers

Age 18 and older

Ability to provide informed consent

Availability for follow up visits

Disqualifiers

Active or recent malignancy (within last 2 years)

Pregnancy or breast-feeding

Inability to provide informed consent

Trial design

Treatments tested in this trial

PrimePro™/ PrimeMSK™

Treatment groups

5,000 Participants

are divided into 10 treatment groups

Treatment groups

See each treatment group below.

Sponsors and collaborators

Thomas Advanced Medical LLC

Lead sponsor

HeartStem Institute

Collaborator

NuStem

Collaborator

Source ClinicalTrials.gov